A Phase 4 interventional study of Tapentadol and Tramadol in Total Knee Replacement, Post-operative Pain and Chronic Pain, sponsored by University of Thessaly. Recruiting at 1 site in Greece. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-05-14.
Sponsored by University of Thessaly · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies testing tapentadol in Pain, Postoperative — 1 open to participants now, 1 under way, none of them phase 3. Tapentadol · Pain, Postoperative.
Among the 12 studies testing tapentadol in Pain, Postoperative, this one is the 6th largest by planned enrollment, is the only one that started in 2023, is one of 2 in phase 4, and was the 11th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →1 of the 12 studies testing tapentadol in Pain, Postoperative is open now, in 1 country.
By country, each count listing its studies:
Tapentadol: first FDA approval 2008 (NUCYNTA). What it is approved for, and how studies give it, is on its page →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 1 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 96 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 91 across the 12 interventional studies. Of the 11 that completed or were terminated, 7 (64%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 12 have an industry lead sponsor. The 8 most frequent:
University of Thessaly is the lead sponsor of 195 studies on the registry; 44 are open to participants now.
University of Thessaly has 3 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 12 studies testing tapentadol in Pain, Postoperative, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Compare the effectiveness of tapentadol and tramadol as part of a multimodal analgesia treatment for Total Knee Replacement (TKR).
As the population ages and becomes more active, the demand for TKR surgery is expected to increase. However, the treatment of TKR pain remains a challenge.
Postoperative pain is associated with longer hospital stays, lower satisfaction, increased opioid consumption, and transition to chronic pain. In TKR, the risk of chronic pain can be as high as 20%.
A suggested method of anesthesia and pain relief is the use of spinal anesthesia along with multimodal analgesia that includes an adductor canal block.
In our hospital, the multimodal analgesia protocol consists of intraoperative sedation with dexmedetomidine, a low dose of ketamine, paracetamol, NSAIDs, and magnesium. Dexamethasone and droperidol are preferred as antiemetics as they can improve the analgesic outcome.
To minimize the use of opioids, the administration of tramadol used to be the standard of care. Tapentadol is an opioid that can be equally effective in the treatment of postoperative pain and reduces the incidence of chronic pain after TKR.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
GFR and eGFR (kidney filtering)
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Tramadol will be administered in a multimodal analgesic approach to manage postoperative pain.
Drug: Tramadol
Tapentadol will be administered in a multimodal analgesic approach to manage postoperative pain.
Drug: Tapentadol
Add tapentadol, for effective pain management in a multimodal setting during TKR.
Add tramadol, for effective pain management in a multimodal setting during TKR.
Post-operative pain
Visual Analogue Scale (VAS) score measures 0 to 10 (0=no pain, 10=the worst pain)
Time frame: 6 hours after surgery
Post-operative pain
Visual Analogue Scale (VAS) score measures 0 to 10 (0=no pain, 10=the worst pain)
Time frame: 12 hours after surgery
Post-operative pain
Visual Analogue Scale (VAS) score measures 0 to 10 (0=no pain, 10=the worst pain)
Time frame: 1st postoperative day
Post-operative pain
Visual Analogue Scale (VAS) score measures 0 to 10 (0=no pain, 10=the worst pain)
Time frame: 2nd postoperative day
Post-operative pain
Visual Analogue Scale (VAS) score measures 0 to 10 (0=no pain, 10=the worst pain)
Time frame: 3rd postoperative day
Post-operative pain
Visual Analogue Scale (VAS) score measures 0 to 10 (0=no pain, 10=the worst pain)
Time frame: 3 weeks after surgery
Post-operative pain
Visual Analogue Scale (VAS) score measures 0 to 10 (0=no pain, 10=the worst pain)
Time frame: 6 weeks after surgery
Post-operative pain
Visual Analogue Scale (VAS) score measures 0 to 10 (0=no pain, 10=the worst pain)
Time frame: 6 months after surgery
Neuropathic pain
PainDETECT (0-35)
Time frame: 6 months after surgery
Quality of life postoperatively
Patient Quality 15 (0-150)
Time frame: 6 months after surgery
Patient Satisfaction
5-point Likert scale (0-5) \[5 representing higher satisfaction\]
Time frame: 5 days after surgery at Discharge
Depression
Patient Health Questionnaire 9 (PHQ9) (0-27) \[The higher the score, more severe the depression\]
Time frame: 5 days after surgery at Discharge
Function
Oxford Knee Score (OKS) (0-48)
Time frame: 6 weeks after surgery
Outcome
Knee Injury and Osteoarthritis Outcome Score (KOOS) (0-100)
Time frame: 6 weeks after surgery
Arthritis impact
ARTHRITIS IMPACT MEASUREMENT SCALES 2 Short Form (AIMS2-SF) (5Likert scale
Time frame: 6 weeks after surgery
Health Status
5 level EuroQol 5 Dimensions 5 level Score (EQ-5D-5L) (0-100) \[The higher the score, the worse the health status\]
Time frame: 6 weeks after surgery
Pain severity
Western Ontario and McMaster Universities Osteoarthritis (WOMAC) (0-96) \[The higher the score the higher the disability due to osteoarthritis\]
Time frame: 6 weeks after surgery
Plan to share: No
Started May 2023 (actual). Primary completion is estimated for May 2025, 24 months after the start.
Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's planned 24 months is above that.
Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Tapentadol · Tramadol